Cano Health Stock Story

CANO

Stock

USD 4.86 0.13 2.61%

Macroaxis Story

The stock is still going through a very aggressive trading activities. Because some of us are getting excited about healthcare space, it makes sense to outline Cano Health in greater detail. We will analyze why it could be a much better year for Cano Health shareholders.

Published over two months ago

View all stories for Cano Health | View All Stories

Do analysts believe Cano Health (NYSE:CANO) will continue to rise?

One of the ways to look at asset utilization of Cano Health is to check how much profit was generated for every dollar of assets it reports. Cano Health shows a negative utilization of assets of -6.66 percent, losing $0.0666 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Cano Health shows how discouraging it operates for each dollar spent on its assets.

What is the right price you would pay to acquire a share of Cano Health? For most investors, it would be the price that gives them a wide margin of safety to have minimal downside risk. In other words, most investors are always looking for undervalued stocks. Even if the future performance is not entirely as expected, the loss of holding it is minimized, and the downside risk is negated.

Please read more on our stock advisor page.

What is happening with Cano Health this year

Annual and quarterly reports issued by Cano Health are formal financial statements that are published yearly and quarterly and sent to Cano Health stockholders. The reports show and break down the current year's ongoing operations and discuss plans for the upcoming year. Annual reports have been a requirement from the Securities and Exchange Commission (SEC) for businesses owned by the public since 1934.

Companies such as Cano Health often view their annual report as an effective marketing tool to disseminate their perspective on company future earnings or innovations. With this in mind, many companies devote large sums of money to making their reports attractive and informative. In such instances, the annual report becomes a forum through which a company can communicate to the general public any number of topics that may or may not be directly related to the actual data published in the reports.

How does Cano Health utilize its cash?

To perform a cash flow analysis of Cano Health, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Cano Health is receiving and how much cash it distributes out in a given period. The Cano Health cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Cano Health Net Cash Flow from Operations is quite stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at (131.91 Million)

Acquisition by Camerlinck Robert of 250000 shares of Cano Health subject to Rule 16b-3

Legal trades by Cano Health insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:

Cano Health insider trading alert for grant of class a common stock by Camerlinck Robert, Chief Operating Officer, on 12th of August 2022. This event was filed by Cano Health Inc with SEC on 2022-08-12. Statement of changes in beneficial ownership - SEC Form 4 [view details]

Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Is Cano Health a risky opportunity?

Let's check the volatility. Cano Health is looking slightly risky at this time. Whether you invest your money or manage your clients' funds, remember that it is easy to forget that behind Cano Health (NYSE:CANO) stock is an actual business venture. So, do not let stock picking become an abstract concept by ignoring the elementary risk calculations. picking up a share of a Cano Health stock makes you a part-owner of that company.

Cano Health Current Consensus

Here is the latest trade recommendation based on an ongoing consensus estimate among financial analysis covering Cano Health. The Cano Health consensus assessment is calculated by taking the average estimates from all of the analysts covering Cano Health

Strong Buy

Hold

Strong Buy	3	75.0
Buy	0	0.0
Hold	1	25.0
Sell	0	0.0
Strong Sell	0	0.0

Another 3 percent rise for Cano Health

Latest kurtosis is at 13.35.

As of the 20th of May, Cano Health shows the risk adjusted performance of 0.0046, and Mean Deviation of 5.28. Cano Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Cano Health, which can be compared to its rivals. Please confirm Cano Health coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Cano Health is priced correctly, providing market reflects its regular price of 6.02 per share. Given that Cano Health has jensen alpha of 0.3996, we suggest you to validate Cano Health's prevailing market performance to make sure the company can sustain itself at a future point.

Our Conclusion on Cano Health

Whereas many of the other players within the medical care facilities industry are still a little expensive, even after the recent corrections, Cano Health may offer a potential longer-term growth to institutional investors. To conclude, as of the 20th of May 2022, our analysis shows that Cano Health hyperactively responds to market trends. The company is undervalued and projects above average odds of financial turmoil for the next 2 years. Our overall 90 days buy-hold-sell advice on the company is Strong Buy.

Editorial Staff

Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management. View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Cano Health. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2022 Macroaxis LLC